Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation(NYSE: XON), announced that the newest addition to its Friendly™ Aedes aegyptimosquito line, "OX5034", will initiate open field trials on May 23, 2018. OX5034 is the next generation of Oxitec's non-biting Friendly™ Aedesmosquitoes, designed to reduce populations of the disease-spreading Aedes aegyptimosquito.
It offers significant advances from the first generation mosquito, known as "OX513A".Oxitec Launches Field Trial in Brazil for Next Generation Addition to Friendly™ Mosquitoes Platform
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться